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ABSTRACT 
Alhawsawi, Sana Mahmoud. M.S., Department of Biological Sciences, 
Wright State University, 2015. β2M antibody is a suitable antibody to 
detect major histocompatibility complex class  as well as α chain 
antibody in healthy tissues and tissues infected with mouse parvovirus 
1. 
 
         Major histocompatibility complex-  (MHC ) is an essential protein located on the 
plasma membrane of every nucleated cell; it contributes to the immune system’s ability 
to defend against bacteria and virus. MHC  displays foreign antigens on the cell surface 
in a manner that encourages CD8+ T cytotoxic cells (CTLs) to respond against these 
antigens by killing the infected cells. MHC  is composed of two chains: a light chain 
(β2- macroglobulin; β2m) and a heavy chain (α chain with 3 domains). The α chain genes 
have different haplotypes, dependent on the strain of mouse. H-2Kb/ H-2Db is the gene 
for the α chain in C57 BL/6 mouse.  
        In this study, we aimed to determine the expression level of MHC  in different 
types of tissues. Since the antibodies for detecting MHC  α chains are very expensive, 
the main goal of the study was to detect both MHC  chains in C57 BL/6 healthy mouse 
tissues and tissues from a mouse infected with parvovirus  by using a less-expensive 
antibody against the β2m chain instead of a monoclonal antibody against the α chain. 
Moreover, the study aimed to determine the amount of MHC  normally expressed in 
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different tissues of C57 BL/6 mouse using immunohistochemistry of paraffin (IHC-P) 
tissue, with the goal of identifying the organs / tissues that express MHC  most 
abundantly. The analyses of data were performed by using One-way ANOVA. 
        We found that the expression of both MHC  chains in different mouse tissues 
(spleen, stomach, small and large intestine) was equivalent and the statistical analysis 
showed that there was no significant difference between the expression of both antibodies 
(H2Kb/H-2Db and β2m) in healthy tissues or in tissue infected with MPV-1. 
Additionally, we observed that the highest MHC  expression level to be in the small 
intestine, with the next highest abundance in the large intestine, followed by the stomach, 
and spleen compared to other healthy tissues (brain, kidney, liver, and heart). Moreover, 
expression of neither MHC  chain could be detected in certain healthy mouse tissue 
(brain, kidney, liver, and heart). In general, the intensity of 3,3'-Diaminobenzidine (DAB) 
(brown coloration) of both MHC  chains was less in healthy tissues in comparison to the 
tissues infected with MPV-1, suggesting that healthy tissue expresses low levels of MHC 
. 
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 Introduction 
         Cells are constantly being exposed to many antigens, including different viruses (Loch and 
Tampe, 2005). This exposure induces a balancing act between the host’s immune system and its 
ability to defend against the virus and the virus’ ability to overcome the host’s defenses (Loch 
and Tampe, 2005). The innate and adaptive immune systems are the two major immune systems 
that play an important role in cells’ protection (Abele and Tampe, 2004). The innate immune 
response is the first defense against invading microbes and it is present in all metazoans. The 
adaptive immune system, only found in vertebrates, assembles antigen-binding molecules 
specific to structures of intracellular or extracellular microbes (Abele and Tampe, 2004). 
Cells involved in adaptive immune responses 
        Two types of cells are involved in antigen recognition in the adaptive immune responses: B 
and T cells. The B cells provide the humoral immunity response, mediated by antibodies 
produced to label the antigen for degradation by macrophages or other accessory immune cells 
(Abele and Tampe, 2004). The T cells are the effector cells in adaptive immunity because they 
recognize microbial (foreign) antigenic peptides displayed on the surface of host cells in 
association with  major histocompatibility complex (MHC) molecules and then proliferate. There 
are two classes of MHC: class  and  (Abele and Tampe 2004). In general, MHC class  (MHC 
) molecules display the foreign peptides to CD8+ T cytotoxic lymphocytes (CTLs) to kill virus- 
infected cells, while the MHC class  (MHC ) molecules display the foreign peptides to the 
CD4+ T helper cells; these cells then stimulate the B cells resulting in production of antibodies 
and other T cell populations to expand (Mellman and Steinman, 2001). Just as this strategy 
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protects the host, viruses have developed ways to counteract this host defense (Loch and Tampe, 
2005).   
MHC class  pathway for antigen presentation  
        The assembly of MHC class  molecules occurs in the endoplasmic reticulum (ER) of cells 
(Li and Raghavanet, 2010). In 2005, Loch and Tampe illustrated the role of MHC  in 
successfully stimulating CTLs which eliminate a number of foreign viral antigens and self– 
antigens with foreign peptides. They described how MHC  molecules bind small viral peptides 
that are degraded by proteasomes. These small viral peptides are moved into the lumen of the ER 
through the transporter associated with antigen processing (TAP) complex. With the help of 
chaperone proteins, such as tapasin, ERp57, and calreticulin, the peptides are loaded onto MHC  
molecules. The peptide-loaded MHC  is then transferred to the surface of the cell via the Golgi 
apparatus and vesicular transport. Once at the cell surface, MHC  molecules display their 
antigen cargo to CTLs (Figure 1). Although this mechanism normally allows the immune system 
to “see” and respond to viral antigens, certain pathogens can evade the normal immune system 
response by targeting MHC  expression by a variety of mechanisms (Loch and Tampe, 2005). 
For instance, viruses have developed several strategies to evade detection and/or destruction by 
vertebrate immune systems (Loch and Tampe, 2005). The “kiss and run” approach is one of the 
strategies used by filoviruses, such as Ebola and Marburg virus, that cause lethal haemorrhagic 
fevers. In the “kiss and run” strategy, the virus replicates very rapidly and the infection develops 
quickly; therefore, the infection is well-established before the immune system has time to 
respond. This mechanism would not be suitable for other viruses with slower replication rates, 
such as retroviruses, including Human Immunodeficiency Virus (HIV).  
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        HIV replicates slowly since viral replication in a host cell requires the process of reverse 
transcription. However, HIV exhibits increased mutation rates due to the lower fidelity of RNA 
replicases and reverse transcriptase. Thus, HIV evades the immune system by constantly 
mutating and therefore the immune system cannot learn how to properly respond to the virus 
(Loch and Tampe, 2005). Additionally, the main mechanism that HIV uses to avoid the immune 
response is to target CD4+ T helper cells (Alimonti et al., 2004). HIV destroys CD4+ T helper 
cells by causing short-lived syncytia of the T cells or raising the susceptibility of the cells to 
death (Alimonti et al., 2003).  
             The ‘‘hit and stay’’ strategy is used by viruses that replicate slowly due to their large 
genomes (120–230 kb). In order to evade immune system recognition, these viruses enter into a 
hibernation-like state in which they avoid being recognized by the immune system by entering 
into a latent phase (Loch and Tampe, 2005). In order to understand additional strategies that 
viruses and other pathogens use to evade vertebrates’ MHC  antigen presentation pathway, it is 
imperative to first understand the synthesis of MHC  and its structure.   
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Figure 1. Overview of processing of antigen presentation by MHC . The proteasomes in the 
cytosol degrade the foreign antigens to form small peptides that load into TAP. TAP bind to the 
peptide-loading complex, MHC , tapasin, calreticulin, calnexin, and ERp57, to transport the 
loaded peptides from the cell cytosol to plasma membrane through endoplasmic reticulum. On 
the cell surface, MHC molecules display the peptides to CD8+ T cytotoxic cells (Adapted from 
Loch and Tampe, 2005). 
The expression of MHC  depends on cell’s circumstances and MHC  structure    
          MHC  is present in every nucleated cell of the body except red blood cells (Li and 
Raghavanet, 2010). MHC  glycoprotein is ubiquitously expressed, but tissue-specific expression 
varies in a specific manner. The regulation of MHC  gene expression can occur at the 
transcriptional level by the decrease or increase of certain stimuli. Hence, the up regulation of 
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expression of MHC  is associated with the induction of several autoimmune diseases (Cohen et 
al., 2009). Interestingly, the reduced expression of MHC  glycoprotein is also correlated with 
several cancers and the associated disease progression, therapy resistance and reduced survival 
(Cohen et al., 2009). 
MHC  structure  
       The length of MHC  peptide is 8-10 amino acids (Antoniou and Powis, 2008); MHC  is 
composed of two chains: a 12-kDa short light chain (β2- macroglobulin; β2m) and a 45-kDa long 
heavy chain (α chain with 3 domains) (York and Rock, 1996 (Figure 2). The α chain is polygenic 
and is found on chromosome 6 in humans and chromosome 17 in the mouse (York and Rock, 
1996). 
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MHC Antigens of Human and Mouse 
        The overall organization of MHC  α chains in humans is different than that found in mice. 
The human MHC  α gene is called human leukocyte antigen or “HLA,” and exhibits three class 
 loci (A, B and C). These genes are HLA-A, HLA-B, and HLA-C (Penn Dustin, 2002). Mouse 
MHC  α chain is composed of a gene named “H-2.” The MHC  H-2 gene has three loci (K, D, 
and L) which form H-2K, H-2D, and H-2L. These genes also have different MHC  α chains 
haplotypes, depending on the strain of mouse and are therefore considered “extremely 
polymorphic” (York and Rock, 1996). The MHC  α chain haplotype in these different mouse 
strains is designated by a small letter (a, b,d, k, q, s, etc.). For example, H-2Kb/ H-2Db genes 
 
Figure 2. The structure of MHC  molecules. The MHC  molecule is composed of two chains: a 
light chain (β2m) and a heavy chain (α chain with 3 domains). The heavy chain contains a 
transmembrane region and three extracellular domains: α1, α2, and α3. The α1 and α2 
domains form the polymorphic peptide binding groove fold which CD8 binds.  The α1 and α2 
domains are supported by the α3 domain and are non-covalently bonded to the β2m (Adapted 
from Zhong et al., 2011). 
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encode the α chain of MHC  in C57 BL/6 mice, and are the focus of this study. They encode 
type I glycoproteins of 340 amino acids. They contain a cytoplasmic region, a transmembrane 
region, an extracellular region composed of an α3 immunoglobulin-like domain to which CD8 
binds, and a polymorphic peptide binding region “groove” formed from the α1 and α2 domains 
(York and Rock, 1996). The structure of the MHC  α chain allows various peptides to bind to 
the peptide grooves to support the immune response by generating destructive action against a 
diverse group of antigen peptides (Li and Raghavanet, 2010). 
       β2m is encoded on chromosome 15 in humans and 2 in mice; only one allele is known in 
humans, compared to seven alleles in mice. β2m is  a non-glycosylated protein with nearly 100 
amino acids (York and Rock, 1996). β2m is not significantly polymorphic and is similar in all 
mammals. β2m associates with the α chain and helps maintain the proper conformation of the 
molecule. In spite of the absence of a transmembrane domain in β2m, it remains associated with 
cells by interacting with the extracellular region of the α chain. (York and Rock, 1996).  
         In 2008, Antoniou and Powis illustrated how MHC  is assembled (Figure 3). The 
formation of the MHC  glycoprotein in ER occurs in two phases. The early stage involves 
control of the folding of the alpha chain with the β2m chain. The late stage includes the 
formation of the ‘peptide-loading complex’ (PLC). In the first stage, the α chains bind to 
calnexin, a transmembrane-bound chaperone that assists in folding the α chains by the aid of a 
monoglucosylated (Man9GlcNAc2Glc1) sugar moiety chemically linked to the conserved 
asparagine at position 86 of the α chains (Antoniou and Powis, 2008). The glycan portion of the 
calnexin’s structure connects MHC  α chains with the extended proline-rich domain, which 
promotes formation of a ‘folding cage’ for the initial stages of assembly. Figure 3 shows how the 
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proline-rich domain also recruits oxido-reductase ERp57, a member of the protein disulphide 
isomerase family of proteins that decreases either oxidized or isomerized disulphided bonds. Due 
to the ability of ERp57 to form several direct conjugates with the α chain, ERp57 has been 
described as a protein that is able to affect the different folding stages of the MHC  α chains. In 
the late stage, immunoglobulin-binding protein (BiP) also binds to the MHC  α chain, to aid in 
folding and assembly of newly synthesized proteins in the RE (Pidoux and Armstrong, 1993); it 
is speculated that BiP may bind, transiently or for a prolonged period, to newly synthesized or 
misfolded proteins in the MHC  α chains (Antoniou and Powis, 2008). Once the calnexin has 
aided in folding the MHC  within the β2m, the calnexin is displaced and transported by another 
soluble ER lectin chaperone, calreticulin, which, like calnexin, possesses an extended proline-
rich domain that recruits ERp57 (Antoniou and Powis, 2008). With the aid of Tapasin (TPN), an 
MHC  accessory molecule, the calreticulin binds to TAP for PLC formation. PLC is essential to 
facilitate proper MHC  loading before transit to the cell surface (Figure 4). 
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Figure 3. Stages of major histocompatibility complex-  (MHC ) assembly. Step 1: It is 
proposed that the newly made/misfolded α chain interacts with immunoglobulin-binding protein 
(BiP). Step 2:  Calnexin (CNX) interacts with the new α chains through a monoglucosylated 
sugar moiety (shown as “G”). The connection between BiP and calnexin-associated α chain is 
not understood. Step 3: CNX recruits ERp57 to assist in folding the native protein. Steps 4 and 5: 
ERp57 directly associates with MHC -  α chain. Step 6: The interaction between MHC  α and 
b2m leads to the displacement of calnexin and induces formation of disulphide bonds (Adapted 
from Antoniou and Powis, 2008). 
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Figure 4. The peptide loading complex (PLC). MHC  α chain associates with TPN and the 
two are tethered to the transporter associated with antigen processing (TAP) complex. TPN is 
bound to ERp57 via a disulphide bond (Adapted from Antoniou and Powis, 2008). 
Examples of pathogenic evasion strategies for the MHC  assembly pathway 
        One of the fundamental questions in immunology research is whether MHC  expression is 
decreased during intracellular infection caused by bacterial agents. Some researchers support the 
idea that MHC  expression is reduced during bacterial infection (Zhong et al., 2000), while 
others do not (Kagebein et al., 2014). For example, during Chlamydia trachomatis infection, 
some authors attribute the occurrence of the infection to the specific mechanism and factors that 
help to down-regulate MHC  expression. 
        Chlamydia trachomatis is an obligate intracellular bacterial pathogen that persists in 
eukaryote host cells (Zhong et al., 2000). Usually, this gram-negative bacterium targets the 
 
11 
 
 
epithelial cells of the urogenital tract and conjunctiva (Kagebein et al., 2014). It has two forms 
during its life cycle (Ibana et al., 2011). The infectious elementary body (EB) is the first form of 
Chlamydia trachomatis and is metabolically inactive. This EB rapidly differentiates into a 
noninfectious intracellular reticulate body (RB) that is metabolically active and has the ability to 
replicate inside cytoplasmic parasitophorous vacuoles termed inclusions (Kagebein et al., 2014). 
Before the RBs leave the infected cells, they replicate again to form EB in order to infect new 
cells. Chlamydia trachomatis can cause severe human and animal diseases (Kagebein et al., 
2014). For example, Chlamydia trachomatis serovars A-C can cause blindness if they infect the 
conjunctival epithelial cells and serovars D-F can cause sexually transmitted infection if they 
infect the columnar epithelium of the genital tract (Ibana et al., 2011). The female endocervix is 
the most common entry gate for Chlamydia trachomatis serovars D-F infection, leading to acute 
salpingitis, pelvic inflammatory disease, chronic pain, ectopic pregnancy, and infertility 
(Kagebein et al., 2014).    
       In 2000, Zhong et al. illustrated the mechanism by which Chlamydia trachomatis evades the 
immune response by reducing MHC  expression. They pointed out that chlamydia protease-like 
activity factor (CPAF), which is sensitive to lactacystin, is the main virulence factor that down-
regulates MHC  expression in Chlamydia trachomatis infected endocervix HeLa and other cells 
such as airway epithelial and fibroblast cells. They determined that CPAF has the ability to 
inhibit the RFX5 complex, an important transcription factor needed for both constitutive and 
IFN-γ-induced MHC  expression. CPAF also inhibits the upstream stimulation factor (USF)-1 
which is a cellular transcription factor for MHC . Overall, in 2000, Zhong et al. concluded that 
 
12 
 
 
the Chlamydia trachomatis reduced the expression of MHC  by inhibiting the host transcription 
factors USF-1 and RFX5.     
        In addition to bacterial pathogens such as Chlamydia trachomatis, many viruses have also 
developed several strategies for evading the host’s immune response through modification of 
antigen processing involving MHC  molecules. This group includes Herpes simplex virus -1 
(HSV-1), which evades the normal immune system response by targeting MHC  expression 
(Loch and Tampe, 2005). HSV-1 is a member of Alphaherpesvirinae family. 
        The Herpes viruses are characterized as having large double-stranded DNA genome and an 
icosahedral nucleocapsid surrounded by a lipid layer envelope (Kruse et al., 2000). About 90% 
of the human population is infected with HSV-1 (Loch and Tampe, 2005). Within the United 
States alone, more than 20,000 new cases of ocular HSV-1 infection and an additional 28,000 
cases of reactivation occur yearly (Shah et al., 2010). Once the infection occurs, it persists for the 
remainder of the host’s life, alternating between lytic and latent phases within ganglia of the 
nervous system (Imai et al., 2013). HSV-1 evades the immune system by inhibiting the 
expression of MHC  by a variety of mechanisms (Imai et al., 2013). This virus synthesizes two 
main proteins: infected cell protein (ICP47) and virion host shutoff protein (vhs) (Imai et al., 
2013). The ICP47 protein typically targets TAP by preventing peptide binding to TAP and then 
impedes MHC  expression on the surface of infected cells (Imai et al., 2013). Vhs is able to 
down-regulate MHC  expression by preventing the synthesis of HSV-1-host cell proteins and 
the proteins of MHC  molecules in infected cells, an act which helps the virus to escape from 
CD8+ CTLs (Imai et al., 2013). Finally, HSV-1 Us3 is considered an MHC  inhibitor as it binds 
to viral envelope glycoprotein B (gB) (Imai et al., 2013).   
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Mouse parvovirus class 1 (MPV-1) 
       Mice infected with parvovirus class 1 (MPV-1) virus were used in this study to evaluate the 
expression of both MHC  chains in tissues from mice infected with parvovirus. MPV-1 
commonly infects laboratory mice; the virus originated from the Parvoviridae family. The virus 
is one of the autonomous parvoviruses that carry a single-stranded DNA genome surrounded by 
a nonenveloped icosahedral capsid about 25 nm in diameter (Ramirez et al., 1996) (Figure 5). 
The virus contains two viral capsid proteins (VP1 and VP2) in addition to the nonstructural 
proteins (NS1 and NS2) (Bhat et al., 2011). In general, all the autonomous MPVs are lytic viruses 
that replicate during the S phase of the mitotic cell cycle (Ramirez et al., 1996). Targeting the 
host cells during their mitotic division and proliferation may cause severe pathology to fetal and 
newborn mice including abnormalities, osteolytic syndromes, dwarfism, abortion, and 
malformations (Ramirez et al., 1996). Additionally, in adult mice, the virus may cause a 
permanent infection of host’s cells such as intestinal epithelium and hemopoietic system. These 
latently infected cells may undergo proliferation and cause extreme infection, and remain 
throughout the life of the host (Ramirez et al., 1996). In general, parvovirus viruses can cause 
cell death by apoptosis and necrosis or may lead to cell cycle arrest (Chen and Qiu1, 2010). 
       However, in 1995 Jacoby et al., stated that MPV-1 is non lytic virus because, in newborn 
and adult BALB/cByJ mice, the number of infected cells remains almost the same during the 
different periods of infection. Their study revealed that MPV-1 is a nonpathogenic virus. MPV-1 
does not directly cause clinical disease in mice; however, it may contribute to disrupting mouse-
based research due to its ability to affect CTL function and proliferation (Macy et al., 2013). 
MPV-1 was first recognized in the medium of cultured mouse T-cells where it was determined 
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that the virus impeded the ability of certain T lymphocyte clones to “thrive” in culture and 
prevented both T-cell proliferation and the expression of Interleukin-2 (McKisic et al., 1998). 
Additionally, MPV-1 can accelerate T- cell–mediated rejection of tumors, skin allografts, and 
syngeneic skin grafts (Macy et al., 2013). Thus, the virus targets the immune response by several 
mechanisms. One of these is the inhibition of cell-mediated immune response facilitated by 
MPV-1’s targeting of and interfering with T cell proliferation and function; MPV-1 infection can 
decrease cytokine-induced CTL and T helper cell proliferation (McKisic et al., 1998). 
 
 
        Shedding from the urinary, fecal, and perhaps respiratory routes is may be the main 
mechanism of MPV-1 virus transmission (Macy et al., 2011); the infection may occur in all mice 
Figure 5. Generic autonomous parvovirus with single-stranded DNA genome and 
nonenveloped icosahedral capsid. The single-stranded DNA genome surrounded by a 
nonenveloped icosahedral capsid, about 25 nm in diameter. The capsid consists 60 copies of 
CP protein. (Adapted from http://viralzone.expasy.org/all_by_species/103.html) 
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strains at any age. Some factors increase the rate of the infection; these factors include the 
mouse’s lifespan, strain, dose and strain of MPV (Macy et al., 2013). In newborn and adult mice, 
the primary target of MPV-1 infection is the lymphoid tissue (Jacoby and Ball-Goodrich, 1995), 
including small intestinal cells (Peyer’s patches), thymus, spleen, peripheral lymph nodes, and 
mesenteric lymph nodes (Mellman et al., 2001). In newborn mice, one of the major target organs 
for parvovirus infection is the brain, including the cerebrum and cerebellum (Ramirez et al., 
1996). Different levels of nonpathogenic MPV-1 expression were also reported in kidney, liver, 
lung, large intestine and stomach (Jacoby et al., 1995).  
Significance of MHC   
       This study utilizes a mouse model with the ultimate goal of extrapolating these data to the 
human. Since the focus of prior research has been on human MHC  (α and β chains) (Guzman et 
al., 2010), we wanted to confirm this study using the mouse model. In addition to the well-
known role of the human MHC  glycoprotein in the immune response, it also plays an important 
role in the predisposition to disease and transplantation complications. An example of the latter 
is the rejection of human liver grafts. In the normal human liver, the expression of both MHC  
chains was found to be low to nonexistent (Steinhoff et al., 1990). Following a liver transplant, 
the donor cells were targeted by the recipient’s immune system leading to graft rejection. After 
transplantation of the liver and during rejection, the expression of human MHC  was greatly 
increased in the plasma membrane of the hepatocytes, bile duct epithelia, endothelia, and Kupffer 
cells. Also, the high expression of MHC  was detectable during both inflammatory and 
infectious processes; a clinical investigation of HLA by typing test matching of the patient's 
HLA antigens showed a dualistic effect of matching MHC  antigens between donor and 
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recipient cells (Steinhoff et al., 1990). This study concluded that MHC  plays an important role 
in graft rejection (Steinhoff et al., 1990) and, in order for grafts to be accepted, the MHC  
antigen needs to matched in donor and recipient cells (Carcia et al., 2012).  
         Recent studies have illustrated that human MHC  is associated with several autoimmune 
and inflammatory diseases, including lupus, erythematosus, rheumatoid arthritis, multiple 
sclerosis, Crohn’s disease, ulcerative colitis, and type 1 diabetes (Fernando et al., 2008). In 
autoimmune diseases, the immune system treats self and foreign-antigens in the same manner, 
which means that immune system recognizes self-antigens as foreign and destroys the body 
tissues, causing the inflammatory disease (Relle and Schwarting, 2012). The mechanism 
underlying the role of human MHC  is not well understood; the disequilibrium alleles at 
multiple loci throughout the human MHC  may be the primary reason for autoimmune diseases 
(Fernando et al., 2008).  
Study objective/ aims      
      In this study we evaluated the expression level of MHC  in different types of tissues. Since 
the antibodies for detecting MHC  α chains are very expensive (Ferre et al., 2012) (to the extent 
that their high cost has impeded research in this area) (Liu, 2014), the main goal of the study was 
to explore a potential method for detection of MHC  molecules, both in healthy tissues and 
tissues from a mouse infected with parvovirus, using a less-expensive antibody against β2m 
chain instead of against the α chain. Moreover, a separate aim was to determine the amount of 
MHC  normally expressed on different tissues of C57 BL/6 mouse using immunohistochemistry 
of paraffin (IHC-P) sections technique, with the goal of identifying the organs / tissues that 
express MHC  most heavily.  
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       Given these general goals, this study specifically determined whether MHC  (α and β 
chains) is continuously expressed in healthy C57 BL/6 mice and evaluated if MHC  molecules 
could be detected using antibodies against the light chain β2m, as well as using antibody against 
the α chain H-2Kb/ H-2Db. Towards this end, we used immunohistochemistry techniques to 
detect MHC  in normal and parvovirus infected tissues of mice. The tissues examined were the 
gut (stomach, large, and small intestine), spleen, kidney, liver, brain and heart. This project 
studied the distribution of MHC  molecules within the body in order to determine which organs 
are more abundant in expression of MHC  molecules on the surface of cells located in the heart, 
brain, kidney, liver, spleen, and gut. In this study, the brain and heart were also used as controls 
because we did not expect MHC  expression in these healthy tissues. Murphy et al. (1996) stated 
that MHC  expression could not be detected in any cell type of the healthy brain. MHC  α and β 
chains were detected by immunostaining of IHC-P sections. To ensure accurate staining patterns, 
each experiment included negative control sections that were not exposed to the full complement 
of antibodies and should not stain. These negative controls were used to determine the 
background level of nonspecific antibody binding (Burry, 2000). The negative control sections 
should not show MHC  signal due to the lack of binding of the primary antibody, secondary 
antibody, or the substrate for each section (Shi et al., 1991). 
Hypotheses  
      We hypothesized that the antibody against β2m could be used as effectively as the alpha 
chain antibody to detect the MHC  glycoprotein in different cells types in both healthy and 
parvovirus infected tissues of mice. Secondarily, we hypothesized that we would be able to 
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determine which tissues of the healthy C57 BL/6 mouse (kidney, liver, spleen, and gut tissues, 
but not in on heart or brain) highly expressed MHC  molecules.  
Material and Methods   
Tissues and paraffin blocking. Two C57 BL/6 (male and female) mice were the source of the 
fresh healthy mice tissue whereas another two male C57 BL/6 mice that were naturally exposed 
to MPV-1 infection were the source of infected tissues. The virus was detected during routine 
health monitoring procedures for the animal facility. The test used was multiplex fluorescent 
immunoassay-2 (MFI2), and was virus confirmed with an indirect fluorescent antibody (IFA) 
test. Collected C57BL/6 mice serum showed positive serology results for MPV-1 in these mice. The 
heathy mice were 2-7 months old whereas the infected mice were newborn, 22 days old. We 
used the tissue of newborn infected C57 BL/6 mice because they were the only available tissue at 
the time since the rest of the mouse colony was destroyed. All the tissues were generously 
provided by Dr. Emily Dudley from Wright State University’s Laboratory Animal Research 
(LAR) unit. Following the procedures established by Robertson et al. (2008) for 
paraformaldehyde -fixed paraffin-embedded tissues, the C57 BL/6 mouse tissues were fixed in 
4% paraformaldehyde (to preserve cell morphology) for 24 h at room temperature (RT). To clear 
the specimens of formaldehyde, the tissues were washed with tap water for 24 hours at RT after 
they were cut to smaller pieces. Then specimens were dehydrated by soaking in 50% ethanol 
(ETOH) for 30 min, 70% ETOH overnight, 95% ETOH for 60 min, and 100% ETOH three times 
for 60 min each time, with all soakings performed at RT. The tissues were then immersed in 
histoClear three times each for an hour at RT, and then placed on histoClear mixed with melted 
paraffin for an hour at 62 Cᵒ. The paraffin was Paraplast Tissue Embedding Media with a 
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maximum temperature 56 Cᵒ, which was purchased from the Fisher Scientific Company (catalog 
# 23-021-400; Houston, TX). The tissues were then added to two consecutive charges of the pure 
paraffin for 60 min at 62 Cᵒ. Finally, the specimens were embedded in fresh paraffin. The tissues 
were cut into 4 µm sections and placed in warm distilled water (~ 40°C) and picked up on glass 
Plus slides (Robertson et al., 2008). The slides were incubated on a vertical rack overnight in the 
oven at 62°C (Robertson et al., 2008). The standard protocol (Robertson et al., 2008) for the IHC 
of paraffin (IHC-P) tissues and “chromogenic” staining (or immunoperoxidase) was performed.  
  Immunohistochemistry procedure of paraffin sections for both MHC  chains 
a. Deparaffinizing and Rehydration 
1- The paraffin was removed by immersing the slides twice in xylene for 10 min each at RT. 
2- The slides were dehydrated with graded ETOH concentrations: two times with 100% ETOH 
solution for 10 min and one time each with 95%, 80%, and 60%, each for 5 min at RT.  
3- The slides were then washed with distilled water three times for 3 min each. 
b. Antigen retrieval 
4- Antigen retrieval was used to reduce excessive cross-linking of the proteins during the 
fixation. In this technique the masking of an epitope is reversed and epitope-antibody binding is 
restored. It was performed using citrate buffer pH 8 at 95-99ᵒC in the water bath for 25 min.  
5- The slides were transferred to a container filled with a sufficient volume of citrate buffer to 
cover the slides, and then the container was placed in a water bath at 95-99ᵒC for 25 min and the 
sections were allowed to cool in the citrate buffer until the buffer reached RT (~30-40 min). 
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c. Incubation with Primary Antibodies 
7- The sections were washed with 1X Tris-buffered saline (TBS) three times.  
8- The sections were circled with a hydrophobic barrier pen to separate sections from each other. 
9- The tissues were incubated in peroxidase blocking reagent (3% H2O2 in distilled water) for 10 
min to quench endogenous peroxidase activity. 
10- The slides were washed with 1X TBS. 
11- The serum blocking reagent 5% Bovine Serum Albumin (BSA) was added for 1 hour to 
decrease non-specific hydrophobic interactions between the primary antibodies and the 
specimens. 
12- The sections were incubated overnight at 2-8 ᵒC with the primary antibody to target the H-
2Kb/ H-2Db and β2m in healthy tissues and tissues infected with MPV-1 (see Table 1). 500 µl 
primary antibody (H-2Kb/ H-2Db #114602) was generously provided by BioLegend (114602, 
San Diego, CA) to help validate its use for IHC-P sections, as it was originally designed for 
immunohistochemistry of frozen sections.  
d. Secondary Antibody Incubation and Detection 
13- The slides were washed three times with 1X TBS for 3 min each.  
14-The sections were incubated with secondary antibodies conjugated to enzymatic horseradish 
peroxidase (HRP) for 30 min in a humidified chamber see (Table 1). 
15- The samples were washed with TBS three times each for 3 min.  
 
21 
 
 
16- The sections were then incubated with DAB (ImmPACT™ DAB Substrate # SK-4105, 
Vector Laboratories, Burlingame, CA) for 10 min. The DAB chromogen solution assists in 
localization of antigen expression as the chromogenic substrate is converted by the HRP enzyme 
into an insoluble end product. 
17- The samples were then soaked in a container with distilled water for 5 min. 
18- For greater clarification of tissue histology, hematoxylin was used for three min (Hematoxlin 
Nuclear Countersigning (Gill’s Formula) Vector # H-3401, Burlingame, CA).  
19- The slides were dehydrated by sequential baths in 60%, 80%, 90% and 100% ETOH 
solutions for 5 min each.  
20- The slides were immersed in xylene twice for 5 min each. 
21- Permount medium was added to cover the stained samples. 
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Table 1. List of type, source, and dilution of the antibodies used to perform immunochemistry 
staining. 
Antibodies 
type 
MHC  (H-2Kb/ H-
2Db)  
in healthy tissues 
 
MHC  (β2m) in 
healthy tissues 
MHC  (H-2Kb/ H-
2Db) in tissues infected 
with MPV-1 
MHC  (β2m) in 
tissues infected 
with MPV-1 
Primary 
MHC  
(Purified mouse 
(C3H) IgG2a, κ anti-
mouse H-2Kb/ H-
2Db antibody from 
BioLegend catalog # 
114602, San Diego, 
CA). 
 
 
 
used concentrated 
“undiluted” 
Purified anti-mouse 
antibody (β2m 
polyclonal rabbit 
IgG) from 
proteintech 
antibody people 
trust, catalog # 
13511-1-AP 
Chicago, IL). 
 
used concentrated 
“undiluted” 
(Purified mouse 
(C3H) IgG2a, κ anti-
mouse H-2Kb/ H-
2Db antibody from 
BioLegend catalog # 
114602, San Diego, 
CA) 
 
 
 
diluted 1:10 in TBS 
Purified anti-
mouse antibody  
(β2m polyclonal 
rabbit IgG) from 
proteintech 
antibody people 
trust, catalog # 
13511-1-AP 
Chicago, IL) 
 
diluted 1:10 TBS 
Secondary 
MHC  
 
 
 
 
 
 
 
 
 
(HRP Goat anti-
mouse IgG (minimal 
x-reactivity, 
antibody)  
Biolegend catalog # 
05302, San Diego, 
CA). 
 
 
diluted 1:500 in TBS 
Goat anti-rabbit 
IgG, conjugated to 
enzyme horse 
radish peroxidase 
(HRP);  
ThermoFisher,  
catalog # 31460 
Carlsbad, CA). 
 
diluted 1:1500 in 
2% BSA/PBS. 
(HRP Goat anti-
mouse IgG (minimal 
x-reactivity, 
antibody) Biolegend, 
catalog # 05302, San 
Diego, CA) 
 
 
 
diluted 1:500 in TBS 
Goat anti-rabbit 
IgG, conjugated to 
enzyme horse 
radish peroxidase 
(HRP); 
ThermoFisher, 
catalog # 31460 
Carlsbad, CA) 
 
diluted 1:1500 in 
2% BSA/PBS. 
 
Immunohistochemistry controls  
      Control slides were required for each antibody staining and were subjected to the same 
conditions as experimental slides. Control sections received identical treatment to all 
experimental sections. We used three different controls to ensure that the signal detection of 
MHC  was a result of the labeling the target MHC  in both chains and not due to nonspecific 
binding/staining, such as non-quenching the endogenous peroxidase activity (Burry, 2010). 
Control slides also provided an opportunity to evaluate the reagents. We designed three negative 
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controls for each organ: ‘no primary antibody, ‘no secondary antibody’, and the ‘substrate only’. 
For the first control, the primary antibody showed that binding occurred only to the target protein 
epitope on the expected antigen of the specific species (Burry, 2010). Under the same conditions 
as the experimental serial tissue sections, the secondary antibody only was applied to show that 
binding occurred only to the primary antibody (Burry, 2010).The substrate control showed that 
the detection of the target protein occurred due to the interaction between the enzyme conjugated 
to secondary antibody and the chromogenic labeling DAB substrate. It also showed that there 
was no background staining and the quenching procedure for endogenous peroxidase activity 
worked effectively. 
Light microscopy/ grids template paper  
       A Nikon light microscope with attached color camera and connection to a color printer was 
used to image and analyze the DAB-staining of both MHC  chains, under the oil immersion, 
63X objective lens. Using printed copies of the photomicrograph images and grid paper, we 
counted and compared the percentage of cells stained by the heavy chain and light chain per unit 
area. We classified the stained images into four categories based on the intensity of DBA 
staining in the cells, (0) no staining, (1) weak staining, (2) moderate staining, and (3) strong 
staining (Rizzardi et al., 2012). 
Statistical analyses  
      Statistical analysis was performed for the total stained cells per unit of area using Sigma Plot 
12.0 software. The total numbers of stained and unstained cells (based on observation of color of 
DAB) were counted and compared between both MHC  chains. The percentage of positive 
stained cells for both MHC  chains was determined. The experiments were performed at least 
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three times in each type of tissue; all illustrated similar results. Representative images or data are 
shown. The values are expressed as the means +/- standard deviation or standard error of the 
mean determined using One-way ANOVA.  Statistical differences were determined between 
groups (i.e., spleen, liver, gut, and kidney) or alpha vs. beta chains with P- values ˃ 0. 05 being 
considered statistically significant.  
Results 
Immunohistochemistry of paraffin for both MHC chains in healthy tissues: 
        Tissues from healthy mice were used to determine if antibodies against β2m can be used as 
effectively as the antibodies against α chains to detect MHC  molecules and to determine which 
tissues express more MHC  molecules in C57 BL/6 mice. Large and small intestine, stomach, 
spleen, kidney, liver, heart and brain from healthy C57 BL/6 mice were examined. To demonstrate 
the expression of both MHC  chains, IHC staining on paraffin embedded sections was performed. 
Four µm serial sections of each tissue type and condition were incubated overnight with the 
primary antibodies to target H-2Kb/ H-2Db or β2m. The primary antibodies were localized with 
conjugated HRP secondary antibodies. The two antibodies were detected with DAB chromogen 
solution, which produces a dark brown colored precipitate in the regions of the antigens of interest 
(MHC  both chains) under bright field microscopy; the intensity of the brown color increases in 
regions with more antigen (Nguyen et al., 2013). By using template paper grids, we counted and 
compared the cells that stained positively with MHC  H-2Kb/ H-2Db and β2m antibodies per unit 
area. Images shown in Figure 6 represent serial sections of the positive staining of the large 
intestine stained with a primary antibody against MHC  H-2Kb/H-2Db and β2m, and a goat anti-
rabbit secondary antibody conjugated to HRP (a), ‘no primary antibody’ (b), ‘no secondary 
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antibody’ (c) and ‘substrate only’ (d), respectively. For tissue stained with the DAB substrate, the 
intensity of brown coloration was less in healthy tissues. Staining was weak to moderate (with 
color scores of 1-2) in comparison to the tissues infected with MPV-1, which express the DBA 
strongly (color scores of 3) (date of unhealthy tissues shown later). The three negative controls 
showed no staining (score of 0). Images shown in Figure 7 represent serial sections of the spleen. 
These stained lightly, the intensity of DBA was low with a primary antibody against MHC  H-
2Kb/H-2Db and β2m, and a goat anti-rabbit secondary antibody conjugated to HRP (a), ‘no 
primary antibody’ (b), ‘no secondary antibody’ (c) and ‘substrate only’ (d), respectively. Figure 8 
shows the positive expression of both MHC  chains of the stomach (a) and small intestine (b) 
stained with a primary antibody against MHC  H-2Kb/ H-2Db and β2m, and a goat anti-rabbit 
secondary antibody conjugated to HRP, respectively. These results suggest that the gut tissues 
contain an abundance of MHC  protein in comparison to other tissues.  
       On the other hand, the sections of liver, kidney, brain, and heart revealed no staining for the 
primary antibody when treated with 1:10 dilution and the same tissues showed a high level of 
background staining when the sections were treated with the pure concentrated primary antibody. 
Thus, these images showed only background staining. Figures 9 and 10 represent 4 µm sections of 
the brain and kidney, respectively, stained with primary antibody against MHC  H-2Kb/ H-2Db 
and β2m and a goat anti-mouse/rabbit, respectively, secondary antibody conjugated to HRP (a), 
‘no primary antibody’ (b), ‘no secondary antibody’ (c), and ‘substrate only’ (d). These results 
indicate that antibodies to H-2Kb/ H-2Db and β2m are appropriate to detect MHC  glycoprotein 
in healthy mouse tissues only for tissues that contain abundant amounts of MHC  protein or for 
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tissues that have experienced some form of immune activation (infection, tumor, or transplantation 
or administration of inflammatory cytokines that would cause an up-regulation of MHC ).  
         We also found the highest MHC  expression level in the small intestine, large intestine, 
stomach, and spleen respectively (Figure 11). Approximately 99% of the small intestinal tissue 
stained positively whereas only ~9% of spleen tissue stained positively. No positive staining 
appeared in brain, kidney, liver, or heart tissue. In general, the stained images demonstrates that 
the expression of both MHC  chains in different mouse tissues (e.g., spleen, stomach, small and 
large intestine) was detectable and the statistical analysis showed that there was no significant 
difference between the expressions of H2Kb/H-2Db antibody versus β2m antibody in healthy 
tissues. The expression of both MHC  chains was equal (p value is ˃ 0.050) (Figure 11). These 
results indicate that the antibody against β2m is as effective at detecting MHC  glycoprotein as 
the antibody against the α chain in C57 BL/6 mouse tissues. 
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H-2Kb/ H-2Db                β2m 
Figure 6. Images representing immunohistochemistry of serial 4 µm paraffin sections of normal C57 
BL/6 mouse large intestine tissue. The tissue stained with primary antibodies against MHC  H2Kb/H-2Db 
(left) and β2m (right) chains and a goat anti-rabbit secondary antibody conjugated to HRP (a), no primary 
antibody (b), no secondary antibody (c), and substrate only (d). The healthy cells show equivalent positive 
expression of both MHC  chains in comparison to control sections. Bar marker = 1mm. 
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Figure 7. Images representing immunohistochemistry of serial 4 µm paraffin sections of 
normal C57 BL/6 mouse spleen tissue. The tissue stained with primary antibodies against 
MHC  H2Kb/H-2Db (left) and β2m (right) chains and a goat anti-rabbit secondary antibody 
conjugated to HRP (a), no primary antibody (b), no secondary antibody (c), and substrate only 
(d). The healthy cells show equivalent expression of both MHC  chains in comparison to 
controls sections. Bar marker = 1mm. 
H-2Kb/H-2Db                   β2m 
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Figure 8. Images representing immunohistochemistry of serial 4 µm paraffin sections of 
normal C57 BL/6 mouse gut tissues. The gut tissues are stomach (a) and small intestine (b) 
stained with primary antibodies against MHC  H2Kb/H-2Db (left) and β2m (right) chains and a 
goat anti-rabbit secondary antibody conjugated to HRP. The healthy cells show equivalent 
expression of both MHC  chains. Bar marker = 1mm. 
 
 
 
H-2Kb/H-2Db                           β2m 
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Figure9. Images representing immunohistochemistry of serial 4 µm paraffin sections of the 
normal C57 BL/6 mouse brain tissue. The tissue shows no staining with primary antibodies 
against MHC  H2Kb/H-2Db (left) and β2m (right) chains and a goat anti-rabbit secondary 
antibody conjugated to HRP (a), no primary antibody (b), no secondary antibody (c), and substrate 
only (d). Bar marker = 1mm.  
H-2Kb/H-2Db                  β2m                         
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Figure 10. Images representing immunohistochemistry of serial 4 µm paraffin sections of the 
normal C57 BL/6 mouse kidney tissue. The tissue stained with primary antibodies against MHC-
 H2Kb/H-2Db (left) and β2m (right) chains and a goat anti-rabbit secondary antibody conjugated 
to HRP (a), no primary antibody (b), no secondary antibody (c), and substrate only (d). The healthy 
cells show a background staining for both MHC  chains in comparison to controls sections. Bar 
marker = 1mm. 
H2-Kb/H-2Db           β2m 
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Figure 11. The expression of MHC   as shown by H-2Kb/ H-2Db versus β2m in different 
normal C57 BL/6 mouse tissues. Statistically there was no significant difference between the 
two chains for all tissue types. The highest expression level of MHC  was in small intestine 
tissue and the lowest expression was in spleen tissue. MHC  was not detected in kidney, heart, 
liver or brain tissue. The analysis was performed by using the One-way ANOVA using Sigma 
plot 12.0 and the graph was generated using Excel. The numbers represent an average of three 
sets of immunostaining. The error bars represent the standard error of the mean [: none 
detectable]. 
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Immunohistochemistry of both MHC   chains in paraffin sections of infected tissues: 
         Immunohistochemistry of paraffin sections was used to detect MHC  expression using 
DAB-chromogen in different tissues from mice infected with MPV-1 to evaluate the effect of the 
MPV-1 on MHC  H-2Kb/ H-2Db and β2m expression and to determine if an antibody against the 
latter is sufficient as an antibody against H-2Kb/ H-2Db to identify MHC  molecules. To 
investigate the expression of both MHC  chains, we performed immunohistochemistry staining 
of serial paraffin sections using DBA-conjugated secondary antibodies to detect both MHC  
chains. The total number of stained and unstained cells was counted and the percentage of positive 
stained cells was determined. We found that the majority of the organs that are the primary targets 
of MPV-1 expressed both MHC   chains (H-2Kb/ H-2Db and β2m) equally and the intensity of 
MHC  expression was at its highest level, with a score of 3, with the antibody against H-2Kb/ H-
2Db and a score of 2-3 with the antibody against β2m. The negative controls revealed no staining 
with scores of 0. Furthermore, we found that the intensity of DBA (brown coloration) staining is 
increased in infected tissues in comparison to healthy tissues. The images in Figure 12 show 
evidence of MHC  expression using antibodies against H-2Kb/ H-2Db or β2m. The images 
represent 4 µm sections of the spleen stained with primary antibody against MHC  H-2Kb/ H-
2Db and β2m and a goat anti-rabbit secondary antibody conjugated to HRP, ‘no primary antibody’, 
‘no secondary antibody’, and ‘substrate only’. Similar results were obtained for the kidney (Figure 
13); Figure 14 shows the same results for the brain (a), stomach (b), small intestine (ileum) (c), 
and large intestine (d); the levels of chromogen staining for theses organs revealed no staining over 
the negative controls (data not shown). The same result was observed with liver tissue (data not 
shown).These results indicate that MPV-1 up regulates the expression of MHC  glycoprotein in 
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infected target tissues. These data also suggest that the expression of both MHC  chains was 
equivalent in different organs.  
         The expression of MHC  was observed in the tissues known to be a primary target of MPV-
1(Jacoby et al., 1995), while non-target tissues did not show any expression of MHC . For 
example, tissue from the heart did not show expression of either MHC  chain (data not shown). 
This result confirms that MHC  is expressed in a tissue-specific manner.  
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Figurer 12. Images representing immunohistochemistry of serial 4 µm paraffin sections of 
MPV-1 infected C57 BL/6 mouse spleen tissue. The tissue stained with primary antibodies 
against MHC  H2Kb/H-2Db (left) and β2m (right) chains and a goat anti-rabbit secondary 
antibody conjugated to HRP (a), no primary antibody (b), no secondary antibody (c), and substrate 
only (d). The images show the levels of expression of shown by both MHC  chains are equal and 
the up regulation of both MHC  chains by MPV-1 infection. The controls sections show no 
expression. Bar marker = 1mm.  
H-2Kb/H-2Db           β2m 
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Figure13. Images representing immunohistochemistry of serial 4 µm paraffin sections of 
MPV-1 infected C57 BL/6 mouse kidney tissue. The tissue stained with primary antibodies 
against MHC  H2Kb/H-2Db (left) and β2m (right) chains and a goat anti-rabbit secondary 
antibody conjugated to HRP (a), no primary antibody (b), no secondary antibody (c), and substrate 
only (d). The images show the levels of expression of shown by both MHC  chains are equal and 
the up regulation of both MHC   chains by MPV-1 infection. The controls sections show no 
expression. Bar marker = 1mm. 
H-2Kb/H-2Db                  β2m 
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H-2Kb/H-2Db                 β2m 
Figure 14. Images represent immunohistochemistry of serial 4 µm paraffin sections of MPV-1 
infected C57/BL several mouse tissues. The tissues stained with primary antibodies against MHC  
H2Kb/H-2Db (left) and β2m (right) chains and a goat anti-rabbit secondary antibody conjugated to 
HRP for the brain (a), stomach (b), small intestine (ileum) (c), and large intestine (d). The images 
show high expression of both MHC  chains in tissues infected MPV-1. Bar marker = 1mm. 
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The expression of H2Kb/H-2Db antibody versus β2m antibody in infected C57 BL/6 mouse 
tissues: 
       When the mean of the positive cells was compared between the antibodies against H-2Kb/H-
2Db versus β2m in infected tissues with MPV-1 (including the spleen, kidney, brain, stomach, 
large and small intestine (ileum)) there was no significant difference between the expression of 
H2Kb/H-2Db versus β2m; the negative control slices did not reveal any positive staining with 
antibodies. Statistical analysis was performed for the mean of the positive stained cells for both 
MHC  chains using One-way ANOVA using Sigma plot 12.0 and the statistical graph was 
generated using Excel. There was no statistically significant difference between all tested groups 
with antibodies against H2Kb/H-2Db versus β2m in infected tissues (p value is ˃ 0.05). This was 
to be expected, given that both chains comprise MHC ; therefore for each α chain, there should 
be equivalent amounts of β2m. These results confirm that the antibody against β2m is as suitable 
to detect the MHC  glycoprotein effectively as the α chain antibody in C57 BL/6 mouse tissues 
infected with MPV-1 (Figure 15). 
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Figure 15. The percentages of positive expression of MHC   chains H-2Kb/ H-2Db versus 
β2m in infected mouse tissues (per unit of area). No significant difference in expression 
occurred between the two primary antibodies and the expression of both MHC  chains was 
equal in all tested tissue. Statistical analysis was performed with using One-way ANOVA using 
Sigma plot 12.0 and the graph was generated using Excel. The numbers represent an average of 
three sets of immunostaining. The error bars represent the standard error of the mean. [ : none 
detectable] 
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Discussion 
      MHC  is an essential protein of every nucleated cell that contributes to the immune system’s 
ability to defend against bacteria and viruses (Loch and Tampe, 2005). MHC  displays foreign 
antigens on the cell surface in a manner that encourages CTLs to respond against these antigens 
by killing the infected cells.  
       In this study, we attempted to answer two questions significant to the immunology field. 
First, since the antibodies for MHC  heavy chain are very expensive, our experiments focused 
on consideration of potential methods for detection of MHC  molecules using an antibody 
against light chain β2m instead of an antibody against α chain in different types of C57 BL/6 
mouse tissues, which may assist in reducing research costs. Second, we designed a series of 
experiments intended to determine the relative expression level of MHC  (α and β2m chains) in 
different types of healthy tissues in C57 BL/6 mice, with the goal of identifying the tissues that 
express MHC  most abundantly. While we used a rodent model, the ultimate goal is to transfer 
this information to humans to find a better approach to reduce the financial cost of evaluating 
MHC  using the very expensive heavy chain monoclonal antibody (Ferre et al., 2012).  
Basis for hypotheses 
        We chose the tissues of the healthy mouse based on their functions and structures. For 
instance, we anticipated that the lymphoid tissues would express a large amount of MHC   
glycoprotein; therefore we expected the spleen to display a high amount of MHC   since it is the 
largest lymphoid organ in the body. Also, the spleen is active with innate immune cells in its 
white pulp, including white blood cells, phagocytic cells (monocyte/macrophages and, NK cells, 
basophils, mast cells, (Ayala et al., 2012) eosinophils and platelets. Additionally, the spleen 
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contains a population of adaptive immune cells T helper, CTLs and B cells, which assist in 
immune reactions against antigens carried by the blood (Steiniger, 2005). Some of the spleen’s 
functions make it likely to be exposed to the pathogens during blood-borne filtration (Steiniger, 
2005). For example, its sinusoid capillary may play a role in pathogen entrance which would be 
expected to induce an increased amount of MHC  expression in this organ. Furthermore, the 
spleen contains a large amount of dendritic cells and some of these dendritic cells are able to 
display foreign peptides on the MHC  glycoprotein for presentation to CTLs (Hey and O’Neil, 
2012).                         
        Additionally, we expected a high amount of MHC  in gut tissues due to their interactions 
with the external environment (via the luminal contents), which routinely expose them to 
bacteria and foreign organisms, in turn stimulating and triggering the immune system and MHC  
glycoprotein. Thus, lymphoid cells are abundant in these tissues, especially in the small intestine. 
The small intestine also contains fenestrated capillaries that have small gaps which allow small 
materials to pass across the capillaries, this also leads to activation of the immune system and 
MHC . 
       Similarly, a principal target of immune response after transplantation are the MHC  
molecules that are expressed on the surface of donor cells; this response may cause a graft 
rejection. We thus expected to detect a significant amount of MHC  expression in the kidney 
since it is one of the most sensitive organs for transplantation (Ayala Garc´ıa et al., 2012).    
       We also anticipated that the liver would be one of the organs that expressed MHC   heavily 
due to the presence of Kupffer cells (that are important in immune response), and because it 
 
42 
 
 
contains about 90 % of the body’s macrophages (Gao et al., 2008). Moreover, the presence of 
sinusoid capillaries in the liver opens the chance of pathogen entry. In humans, the liver 
expresses MHC  heavily during transplantation states (Lee et al., 2012). 
      On the other hand, we expected that there would not be detectable levels MHC  expression 
in the healthy brain or heart due to the absence of lymphoid and myeloid cells which highly 
express MHC . Also, these two organs are not directly exposed to the external environment and 
that may limit their interaction with potential pathogens (Delves et al., 2011). Moreover, these 
two organs are characterized by continuous capillaries which only allow very small molecules, 
water and ions to pass through the tight junction, reducing the chance of infection.  
The advantages of using paraformaldehyde -fixed paraffin-embedded for the IHC-P staining 
       To answer these questions, immunohistochemistry of paraffin-embedded tissues technique 
was performed over two different tissue conditions: heathy/ normal tissues and tissues from 
mouse infected with parvovirus. IHC-P is one of the most effective biomarker techniques for 
locating specific antigen expression in tissues (Nguyen et al., 2013). The advantage of using this 
technique is that it preserves tissue morphology at room temperature for many years, so one can 
go back and rephotograph and reanalyze it (Chen et al., 2010). Also by using paraffin-embedded 
tissue, one can obtain nearly identical serial sections. Although IHC-P samples may undergo 
some tissue shrinkage and antigen masking, the tissue may retain better morphology when the 
antigen retrieval technique is used. IHC of frozen tissue is a technique related to IHC-P, but the 
IHC of frozen tissues may affect tissue structure negatively due to the formation of ice crystals 
which may result in poor tissue morphology (Chen et al., 2010). Additionally, the IHC of frozen 
tissue technique can be preserved for only one year (at - 80 ˚C) (Chen et al., 2010). IHC-P is 
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used in research as well as clinical investigations for several reasons. First, it allows "permanent" 
(for many years) chromogenic staining (Nguyen et al., 2013). Second, details of using the 
technique have been optimized in a number of laboratories (Mukherjee et al., 2010); IHC-P has 
become an important tool in the field of cancer research for tasks such as defining metastatic 
tumors (Mukherjee et al., 2010). Third, IHC-P of tissues has been used for clinical practice. For 
instance, mRNA biomarkers were used to subclassify diffuse large B cell lymphomas (DLBCL) 
into prognostically discrete subtypes (Rizzard et al., 2012); some genes were used for detection 
of the expression of the proteins by performing IHC-P (Rizzard et al., 2012). Therefore, we 
anticipate that it would a useful technique to determine the expression of MHC  molecules.    
MHC  in normal tissues 
        By using the IHC-P detection system, the MHC  expression of both chains was localized 
on serial sections of healthy tissues (spleen, kidney, liver, heart, brain, stomach, small and large 
intestine) to determine if the antibody against β2m is as suitable as the antibody against the α 
chains to detect MHC  in C57 BL/6 mice; then to determine which tissues in the healthy C57 
BL/6 mouse express MHC  most abundantly. The statistical analyses of the expression of MHC 
 H-2Kb/ H-2Db and β2m demonstrated that there was no significant difference between 
prevalence of the chains and ability of the antibody against β2m to detect MHC , confirming 
that β2m is adequate to detect MHC  in different tissues of C57 BL/6 mouse. Also, it was found 
that the expression of both MHC  chains was less in normal mouse tissues in comparison to 
tissues infected with MPV-1. 
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       For the second hypothesis, determination of tissue types that contain MHC  most 
abundantly, the expression of both MHC  chains was detectable in the healthy mouse tissues 
known to be primary sources of lymphoid cells. The gut tissues had the highest level of MHC . 
The stimulation of MHC  expression may be due to the fact that the gut is, in many respects, one 
of the largest components of the immune system (Janeway et al., 2001). Most of the adaptive 
immune response occurs in the gut, particularly the mucosa layer. The gut tissue contains Peyer’s 
patches and some fraction of the lymphoid vessels that line the lamina propria in the mucosa 
layer extend into the submucosa (Janeway et al., 2001). Non-sterilized food in the gut may 
introduce bacteria that stimulate the expression of MHC  in this tissue. The small and large 
intestine, stomach, and spleen were the organs that expressed both MHC  chains most 
abundantly compared to other tested tissues. The negative control spleen sections showed non-
specific staining (light brown staining). To account for this, we only counted the dark brown 
staining which targets both MHC  chains (Figure 8). As we expected the expression of MHC  
was low in the spleen, and appeared non- existent in some of the healthy tissues, including 
kidney and liver, due to the fixation reagent. To reduce the excessive cross-linking of the 
proteins, we used the strong detergent such as Triton X-100 (Bunea et al., 2001).  
        The kidney, liver, brain and heart did not show any staining with 1:10 dilutions of the 
primary antibodies for β2m andH-2Kb/ H-2Db, determined by the fact that the intensity of the 
chromogen staining did not change between the four sections. In other words, the negative 
control slices displayed equal chromogen staining compared with the experimental slides that 
were stained with both the primary and secondary antibodies. When we increased the 
concentration of the primary antibodies to the point of using only undiluted antibody, we 
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observed high background staining even though the blocking of non-specific staining step was 
performed. This non-specific staining may have been due to non-specific binding between the 
primary antibodies and the tissues. Although MHC   glycoprotein is present on every nucleated 
cell membrane in the body, the expression of MHC  needed to be stimulated in certain tissues by 
some forms of immune activation. Lack of expression of both MHC  chains in some healthy 
tissues may indicate low levels of MHC  expression in healthy tissues, or lack of MHC  
stimulation (e.g., infection, tumor or administration of inflammatory cytokines) that would 
activate the immune system. Additionally, the absence of MHC  in these normal tissues may 
refer to cell’s inventive adaptive technique to prevent cell death by CD8+ CTLs and to prevent 
immune mediated pathology. The limited sensitivity between the tissues and the technique may 
affect the expression of MHC  in these tissues. Finally, paraformaldehyde-fixative solution 
probably plays important role in reducing the expression of MHC  in healthy tissues.   
MHC  and tissues infected with MPV-1 
        Confirming the previous result regarding the adequacy of β2m antibody to detect whole 
MHC  molecule instead of using H-2K/bH-2Db antibody, tissues from mice infected with 
parvovirus were used and IHC-P technique was applied. MPV-1 targets the immune response by 
a variety of mechanisms aimed at inhibiting cell-mediated immune response by interfering with 
the ability of cloned T cells to proliferate and respond against the infection.  
        Because the CTLs are one of the primary targets of MPV-1 infection, we expected to detect 
a great amount of MHC  expression in infected organs that modify CTLs and allow them to 
destroy the infected cells. As we expected, the expression of MHC  was up regulated in infected 
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tissues in comparison to the healthy tissues in all target MPV-1 organs, which indicates that the 
virus stimulated the expression of MHC . 
       However, we propose that the mechanism that increases expression of both MHC  chains in 
tissues infected with MPV-1 may involve the activation of innate immunity against viral 
infection either via natural killer (NK) and natural killer T (NKT) cells that produce interferon I 
(IFN-α and IFN β) (Hunter et al., 1997), which ultimately up-regulates the expression of MHC   
in infected tissues (Wan et al., 2012).  
       In 2013, Mattei et al. examined the effect of a common murine parvovirus, minute virus of 
mice (MVMp), on interferon I production in infected C57 BL/6 mouse embryonic fibroblasts. 
The authors found that the expression of IFN-α and IFN-β is increased in tissue infected with 
murine parvovirus but not to the point that it suppresses virus replication. The production of IFN-
γ in responses to viral infection activates the expression of both MHC  chains by enhancement 
of upstream regulatory elements: the SXY module, enhancer A, and IFN stimulated response 
element (ISRE). The last two elements are composed of the two promoters that regulate the 
synthesis of the MHC  gene, nuclear factor-κB (NF-κB) and interferon regulatory factors 
(IRFs), which are controlled by IFN-γ-mediated cytosolic factor, Janus kinase-1 (JAK-1), and 
signal transducer and activator of transcription-1 (STAT-1). In addition to that, the expression of 
MHC  may be increased by the engagement of the binding sites for upstream stimulation factor-
1 (USF-1), USF-2, and stimulation factor-1 that are also present in the upstream regulatory 
promoter elements (Zhou 2009). Although the induction IFN I occurs during the stage of MVMp 
infected mouse embryonic fibroblasts, which lead to the synthesis of MHC  molecules, the 
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parvoviruses may evade the immune system recognition by inducing a delayed IFN response. 
This delay may allow for viral transmission between mice (Mattei et al., 2013). 
        Further, since the MHC  glycoprotein was at its highest level of expression in infected 
cells, both MHC   chains (H-2Kb/ H-2Db and β2m) were expressed equally, which confirmed 
that β2m is a suitable antibody to detected MHC  glycoprotein in C57 BL/6 mice tissues 
infected with MPV-1. For example, images shown in Figures 13 and 14 illustrate the positive 
staining of both MHC  chains “H2Kb/H-2Db antibody versus β2m antibody,” indicating validity 
of the use of β2m antibody instead of the α chain to detect the whole MHC  glycoprotein. This 
result was strengthened by the statistical analyses which showed that there was no significant 
difference (P-value ˃ 0.05) between the expression of the MHC  chains in the same conditions. 
The negative control slices showed no staining by either antibody. The expression of both MHC 
 chains was obvious in the parvovirus infected brain tissue, as we expected. In 2008, McConnell 
et al. confirmed that MHC  expression can be detected in infected MPV-1 neuron cells, 
including cerebral cortex, hippocampus, motoneurons, and the mouse vomeronasal organ. MHC 
 molecules can be detected in neuronal dendrites and synapses, as well. Finally, since MPV-1 
targets specific tissues in the mouse, it would not be appropriate to define normal tissue 
distribution of MHC  in infected tissues.       
Suggestions for further research 
         Since the expression of MHC  in healthy tissues is very low, it may be beneficial to 
investigate a technique that may help to increase the expression of MHC  rather than relying on 
pathogenic activation of the immune system. Lipopolysaccharides (LPS) are molecules 
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containing lipids and a polysaccharide; LPS is found in the outer membrane of gram-negative 
bacteria and it plays an important role in immune system activation (Casals et al., 2007), 
inducing septic shock in humans (Muroi and Tanamoto, 2002). LPS can activate the expression 
of NFκB (Muroi and Tanamoto, 2002) which is involved in up regulation expression of both 
HLA-A/B/C and β2M proteins in undifferentiated pluripotent, normal human fibroblasts, and the 
somatic cells (Pick et al., 2012). Therefore we anticipate that LPS may be a useful reagent to 
increase activation of NFκB and increase the expression level of MHC  in a mouse model in 
vivo (LPS may be administered at a dose 10 microg/ml twice weekly for 4 weeks )(Antonicelli et 
al., 2004).  
            Without the limitations of money and time, one also may be able to increase the low level 
of MHC  expression in normal tissue, since MHC  has the potential to present on every 
nucleated cell in the body. By taking a biopsy from any tissue, such as skeletal muscle (to 
include fibroblasts or myoblasts) from an unhealthy human with MHC  gene mutation, one may 
be able to reprogram these cells into human induced pluripotent stem cell (iPSCs) by using the 
reprogramming factors, differentiate them into myoblasts and provide them a copy of the genes 
encoding MHC  (under a controllable promoter) via a lentivector. These cells will then be 
differentiated into a new muscle cells whose expression of MHC  can be controlled/increased. 
The newly engineered iPSC-derived muscle cells could be transplanted back intramuscularly into 
the patient with the mutated MHC  gene (Tedesco et al., 2012).  
Prior to transplantation, the cells should be evaluated for correct myocyte morphology, 
proliferation, and the up-regulation of MHC  expression using immunofluorescence and/or real-
time PCR analyses (Tedesco et al., 2012). Despite of likelihood of this approach yielding high 
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levels of MHC , it may be costly and utilize a large number of animals to provide strong results. 
Also, it extends the range of possible data and forms a better picture for analysis. This technique 
is aimed at increasing the expression of MHC , which may help to increase the proper function 
of the adaptive immune system.  
      Alternatively, some chemotherapy treatments have been associated with increases in MHC  
expression (Aaqkiozdis, et al., 2011). Specifically, topotecan, a drug targeting topoisomerase I 
stimulates MHC  expression (Wan et al., 2012). Drugs that increase MHC  expression are 
particularly useful in fighting cancers, as they help to invoke an immune tumor-killing activity, 
as well as it induce autoimmune responses (Tsang et al., 2012 ). To use topotecan to increase 
MHC  in a mouse model, one could administer the drug intravenously at a dose of 25 mg/kg 
twice weekly for 4 weeks, after which the animal can be euthanized and tissues harvested, sliced 
and stained using IHC-P (Patel et al., 2013). 
      Moreover, since the IHC-P technique was the only method that was used in this study, follow 
up studies should use different methods that may be more specific and sensitive in detecting 
specific molecules. For example, Western blotting or mRNA analysis for the MHC  protein by 
quantitative real-time PCR analysis that may be more successful at detecting low levels of MHC 
 within tissues, given that extracted nucleic acid or proteins from a large piece of tissue could be 
concentrated (Mahmood and Yang, 2012) and may yield an observable, albeit low, level of MHC 
 (Pick et al., 2012). The disadvantage of this approach is that it requires homogenization of the 
tissue and therefore determining the localization of MHC  molecules within the tissue would not 
be feasible.           
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       Flow cytometry analysis would be a useful method for cell counting and it would give more 
accurate results in determining the number of stained cells since it measures individual cells in 
flow system. Despite the high sensitivity of detection of MHC  expression on the tissues of 
technique, it also destroys the tissue’s structure. Finally, close attention should be given to 
determining the mechanism that MPV-1 uses to evade the immune response. It has been 
suggested that the underlying mechanism of MPV-1 evading the immune system lies in the 
targeting of major immune cells that are the first line of defense against invading microbes.  
MPV-1 interfere with the ability of certain T lymphocyte clones (CD8 and CD4 ) to “thrive” in 
culture and prevents both antigen- induced T-cell proliferation and the expression of Interleukin-
2 (McKisic et al., 1998) Although, MHC  was functioning properly, MPV-1 down regulates the 
proliferation capacity  of alloantigen-reactive CTLs (McKisic et al., 1998)    
        The relevance of this study is based on the premise that clinicians may need to evaluate 
MHC  levels in tissues to determine inflammatory disease. For instance, detection of MHC  has 
diagnostic value for certain idiopathic inflammatory diseases (Van der Pas et al., 2004). 
Specifically neuromuscular diseases, including Duchenne muscular dystrophy, may be able to 
use the antibody against β2m in biopsied muscle tissue to help determine the disease state. The 
cost-effectiveness of this antibody may help to reduce health care costs associated with 
observing MHC  levels in patients. 
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